Exploration of Immunology

Type	Serial number	Clinical stage	Notes
Addressing therapy	NCT04098562	Phase 2	Antibacterial peptide LL-37
NCT01143714	Phase 4	Collagenase
NCT00316537	Phase 1/2	ATG002 is an agonist of the nicotinic acetylcholine (nACh) receptor pathway (pro-angiogenic drug)
Cytotherapy	NCT06231771	Phase 1/2	Allogeneic mesenchymal stromal cells
NCT04104451	Phase 1	Umbilical cord endometrial MSCs
Cytokine therapy	NCT01830348	Phase 3	A peptide analogue of angiotensin II
NCT06020664	Phase 1	Small molecule drugs
NCT04323462	Phase 4	Insulin analog
NCT06383013	Phase 2	Recombinant cytokines

Type

Serial number

Clinical stage

Notes

Addressing therapy

NCT04098562

Phase 2

Antibacterial peptide LL-37

NCT01143714

Phase 4

Collagenase

NCT00316537

Phase 1/2

ATG002 is an agonist of the nicotinic acetylcholine (nACh) receptor pathway (pro-angiogenic drug)

Cytotherapy

NCT06231771

Phase 1/2

Allogeneic mesenchymal stromal cells

NCT04104451

Phase 1

Umbilical cord endometrial MSCs

Cytokine therapy

NCT01830348

Phase 3

A peptide analogue of angiotensin II

NCT06020664

Phase 1

Small molecule drugs

NCT04323462

Phase 4

Insulin analog

NCT06383013

Phase 2

Recombinant cytokines